• Japanese
  • Korean
  • Chinese
Cover Image

Nanotechnology for Medical Diagnostics 2012

Abstract

Following on from our "Nanotechnology for Drug Delivery" series of reports we are turning the focus onto medical diagnostics with our latest report: "Nanotechnology for Medical Diagnostics"

Nanotech enabled medical diagnostics promise to improve just about everything that can be improved from a diagnostics point of view: earlier detection of disease, higher sensitivity, higher accuracy, higher throughput capability, more results per assay; time saving and cost-effectiveness.

As with our "Nanotechnology for Drug Delivery" series of reports, this report provides a market numbers for the nanotech enabled medical diagnostic market between 2000-2010 and a market forecast for the period 2011-2021.

Report Scope

Two sets of data are presented in this report:

  • The TAM growth for NMBD between 2000-2010;
  • TAM forecast for NMBD between 2011- 2021.

Both sets of data are segmented into;

TAM (US$ millions, % share, and CAGR) for:

  • America
  • Asia (key economies)
  • Europe (key economies)
  • RoW (key economies)

Technology type (US$ millions, % share and CAGR) for;

Main Technological Approaches:

  • Quantum dots (QDs);
  • Gold nanoparticles;
  • Cantilevers;
  • Exosomes;
  • Nanobiosensors;

Main Technological Applications:

  • Nanotechnology-based medical and biomedical imaging for diagnostics;
  • Nanotechnology-based medical devices for diagnostics;

Nanotechnology in Early Disease Detection.

Geographical Scope

The studied regions are:

  • North America:
    • USA;
  • European Union (27):
    • Germany;
    • France;
    • UK;
    • Other Countries of EU;
  • Russian Federation
  • Asia:
    • India;
    • Japan;
    • P. R. China;
    • South Korea (R. of Korea);
    • Taiwan;
  • RoW

Quantifying the Total Addressable Market (TAM) Current

The TAM for nanotech enabled diagnostics is estimated to be 2.439 US$ Billion (end of 2011).

Nanotechnology applied to medical imaging and gold nanoparticles for diagnosis were the application and technology respectively, with the highest growth during the last decade, currently (2011 figures) at:

  • Medical Imaging: 1.7 Billion US$
  • Gold Nanoparticles: 959 Million US$

While the US, China and Germany were the countries with the highest growth currently (2011 figures) at:

  • North America: 675 Million US$
  • China: 330 Million US$
  • Germany: 117 Million US$

Forecast

We forecast the TAM for nanotech enabled diagnostics to reach $53.6B in 2021. In comparison our report "Nanotechnology for Drug Delivery" forecasts a TAM of $136B in 2021 for nanotech enabled drug delivery.

In 2021, Asia (China, Japan, South Korea, Taiwan, India combined) tops the list with the highest TAM, China and India are neck and neck for CAGR.

Of all the technologies studied for this report, exosomes for diagnosis show the highest CAGR between 2011-2021 while medical imaging remains the highest growth application of the nanotech enabled diagnostics market in 2021.

Table of Contents

TABLE OF EXHIBITS

  • Chapter One
  • Chapter Two
  • Chapter Three
  • Chapter Four
  • Appendix

Executive Summary

CHAPTER 1

  • INTRODUCTION AND METHODOLOGY
    • Report Scope
    • Scope of Data Analysis
    • Thematic Scope
    • Geographical Scope
    • Methodology
    • Procurement
    • Calculation of CAGR
    • The Nanoscale
    • Two biological examples that illustrate nanoscale:

CHAPTER 2

  • INTRODUCTION TO NANOTECHNOLOGY & MEDICINE - OVERVIEW OF NANOTECHNOLOGY
    • Why is Nanotechnology A Critical Application for Medicine and Biomedicine?
    • Why Nanotechnology Is Needed for Medicine and Biomedicine?
    • WHAT ARE THE KEY DRIVERS FOR ADOPTION OF NANOTECHNOLOGY IN MEDICINE AND
  • BIOMEDICINE?
    • The Aim Of Targeting For Detection, Quantification And Characterization Purposes -
    • Molecular Recognition in Nanotechnology in Medical And Biomedical Diagnostics
    • Reasons Why The Market of Nanotechnology in Medical And Biomedical Diagnostics
    • Expanded so Rapidly During The 2000-2010 Decade
    • Market Drivers For Nanotechnology-Based Medical And Biomedical Diagnostics
    • Reasons Why The Market of Nanotechnology in Medical And Biomedical Diagnostics
    • Rapidly Expand
    • Drivers For Synergies Between Nanotechnology in Medical And Biomedical Diagnostics
    • And Nanotechnology in Drug Delivery
    • Increasing Proportion of The Ageing Population
    • Demand For More Affordable Health Care
    • Public Health - Ending disease
    • Demand For More Innovation
    • Social Responsibility
  • THE MOST IMPORTANT FIELDS IN THE ADOPTION OF NANOTECHNOLOGY IN MEDICINE AND BIOMEDICINE
    • Nanotechnology in Drug Delivery
    • Nanotechnology in Medical and Biomedical Diagnostics
    • Nanotechnology in Regenerative Medicine and Tissue Engineering
    • Other Applications For Nanomaterials In The Medical And Pharmaceutical Sector
  • HOW NANOTECHNOLOGY IS ALREADY HAVING AN IMPACT IN MEDICAL AND BIOMEDICAL DIAGNOSTICS
    • Case Study 1 - Diagnosis of head-and-neck cancer from exhaled breath
    • Case Study 2 - UTSA researchers embracing nanotechnology to accelerate diagnostics
    • Case Study 3 - Biocompatible graphene transistor array reads and records action potentials from electrogenic cells

CHAPTER 3

  • KEY BARRIERS TO THE ADOPTION OF NANOTECHNOLOGY IN MEDICINE AND BIOMEDICINE
    • Nanotoxicity Nanopollution and Nanosafety
    • Ethical Considerations of Nanotherapies
    • Delayed Nanoregulation
  • CURRENT & FUTURE CHALLENGES IN THE ADOPTION OF NANOTECHNOLOGY IN MEDICINE AND BIOMEDICINE
    • Current & Future Challenges of Nanosafety And Risk Management
    • Current & Future Challenges of Nanoregulation
    • Current & Future Challenges of Nanomedicine Industry
    • Current & Future Challenges of Sustained Innovation
    • Current & Future Challenges of Cooperation
    • TAM ANALYSIS, WITHOUT SEGMENTATION (2000-2010)
    • TAM FORECAST , WITHOUT SEGMENTATION (2011-2021)

CHAPTER 4

  • OVERVIEW OF THE KEY NANOTECHNOLOGIES USED IN MEDICAL AND BIOMEDICAL DIAGNOSTICS SORTED BY APPLICATIONS
    • Nanotechnology in Medical and Biomedical Diagnostics: Diagnostics Nanotechnologies
    • Quantum Dots
    • Preparing Quantum Dots
    • Operation of Quantum Dots
    • Detection of Quantum Dots
    • Features And Benefits of Quantum Dots
    • Disadvantages of Quantum Dots
    • Application of Quantum Dots to Medical And Biomedical Nanotechnology-Based
    • Diagnostics Assays
    • Prostate-specific antigen assay
    • Acetylcholine assay
    • Targeting of membrane protein P-glycoprotein (Pgp) in HeLa cells that had been
    • transiently transfected by a plasmid encoding for Pgp
    • Cellular organelles assay
    • Cancer detection assay
    • Imaging assays
    • Gold Nanoparticles
    • Application of Gold nanoparticles to Medical And Biomedical Diagnostics Assays
    • PSA assay
    • Alzheimer's disease BCA
    • BCA as a possible alternative for PCR
    • Cantilevers
    • Application of Cantilevers to Medical And Biomedical Diagnostics Assays
    • Exosomes
    • Microvesicles Overview
    • Microvesicles as Mediators of Intercellular Communication
    • Types of Released Microvesicles
    • Intracellular Origin of Exosomes
    • Exosomes as Nanotechnology in medical and biomedical diagnostics Biomarkers
    • Nanobiosensors
    • Medical and Biomedical Imaging
    • Fluorescent Nanoparticles
    • In vivo nanoparticle-based near-infrared fluorescence (NIRF) imaging techniques
    • Nanobioimaging
    • Nanotechnology-Based Medical Devices For Diagnostic
    • Nanopatterned Medical Devices for Diagnostic
    • Nanoporous Silica Nanochips
    • Nanowire Biosensors
    • Micro- And Nanocantilever Arrays
    • Molecularly Gated Single Electron Transistors
    • The Most Relevant Technologies in The Key Area of Nanotechnology in Medical And
    • Biomedical Diagnostics
  • STAGE OF DEVELOPMENT OF KEY NANOTECHNOLOGIES USED IN MEDICAL AND BIOMEDICAL DIAGNOSTICS
    • Genomics and Proteomics in Nanotechnology in Medical and Biomedical Diagnosis in
    • Context of Personalized Medicine
    • The Potential of The Adoption of Nanotechnology to Medical And Biomedical Diagnostics
    • TAM ANALYSIS, WITH SEGMENTATION (2000-2010)
    • TAM by Country
    • TAM by Key Technology
  • TECHNOLOGY ADOPTION ROADMAP
    • Projected Product Pipeline For Nanotechnology-Based Medical and Biomedical Diagnostics Market
    • Projected Product Pipeline For Nanotechnology-Based Medical Devices For Medical And Biomedical Diagnostics
    • Projected Product Pipeline For Nanotechnology-Based Medical Devices For Theranostics
    • Projected Product Pipeline For Nanotechnology-Based Medical Imaging For Medical And Biomedical Diagnostics
    • TAM FORECAST, WITH SEGMENTATION (2011- 2021)
    • TAM Forecast by Country
    • TAM forecast by Key Technology
  • SWOT ANALYSIS (2011-2021 PERIOD)

APPENDIX

List of Figures

CHAPTER ONE

  • Exhibit 1.1
    • Formula for the calculation of the Compound Annual Growth Rate (CAGR) [2].
  • Exhibit 1.2
    • Formula for the verification of the calculated values of CAGR (2011-2021) [2].
  • Exhibit 1.3
    • Metres in a nanometre (top), nanometres in a metre (bottom)

CHAPTER TWO

  • Exhibit 2.1
    • Illustration of the fact that the periodic table of elements, as we know it (at meter scale) governed by classic Newtonian laws of physics. However, when perceived at nanoscale, those elements are governed by the laws of quantum physics.
  • Exhibit 2.2
    • Proportion of the population aged over 65 and over 80 [8].

CHAPTER THREE

  • Exhibit 3.1
    • Key barriers to the adoption of nanotechnology in medicine and biomedicine (Source: Cientifica, Ltd.).
  • Exhibit 3.2
    • Specified expected barriers in the development of particular types of nanoparticles (Courtesy of CienNanoroadmap Synthesis Report), [6].
  • Exhibit 3.3
    • Table representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in medical and biomedical diagnostics, without segmentation, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 3.4
    • Line chart representing Total Addressable Market, TAM (2000-2010), for nanotechnology in medical and biomedical diagnostics, without segmentation, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 3.5
    • Bar chart representing Total Addressable Market, TAM (2000-2010), for nanotechnology in medical and biomedical diagnostics, without segmentation, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 3.6
    • Table representing the Total Addressable Market, TAM forecast to 2021 (for the 2011- 2021 period), for nanotechnology in medical and biomedical diagnostics, without segmentation, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 3.7
    • Line chart representing the Total Addressable Market, TAM forecast to 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, without segmentation, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 3.8
    • Bar chart representing the Total Addressable Market, TAM forecast to 2021 (for the 2011- 2021 period), for nanotechnology in medical and biomedical diagnostics, without segmentation, source: Cientifica (all figures US$ Million Dollars).

CHAPTER FOUR

  • Exhibit 4.1
    • Summarized comparison of characteristics of quantum dots (QDs), cantilevers and gold nanoparticles in the scope of the adoption of nanotechnology to clinical diagnosis [3].
  • Exhibit 4.2
    • Schematic diagram representing the general structure of a Quantum dot (in this case, a typical CdSe/ZnS QD). The coating extremities can change according to requirements regarding application and biocompatibility (e.g. mercaptoacetic acid or streptavidin) [3].
  • Exhibit 4.3
    • A schematic diagram of a multiplex QD-based assay. Multiple antigens (Ag) can be labelled through the use of primary antibodies (Ab) conjugated to QDs with different sizes. One antibody may be biotinylated and detected with a streptavidin-coated QD. On excitation, QDs will have different emission maxima based on their sizes [3].
  • Exhibit 4.4
    • A summary of toxicity breakthroughs standing on selected quantum dots studies [3].
  • Exhibit 4.5
    • Selected examples of quantum dots-based assays. The presented quantum dots have different recognition moieties [3].
  • Exhibit 4.6
    • Examples of the adoption of nanotechnology to medical and biomedical diagnosis and a summary of the characteristics of those technologies [3].
  • Exhibit 4.7
    • Schematic representation of production and release of exosomes. The exocytic multivesicular bodies may fuse with membrane and release exosomes [4].
  • Exhibit 4.8
    • Table representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in medical and biomedical diagnostics, all countries studied, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.9
    • 3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in medical and biomedical diagnostics, by world regions and countries, source: Cientifica (all figures in percentage).
  • Exhibit 4.10
    • Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in medical and biomedical diagnostics, by world regions and countries, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.11
    • Line chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in medical and biomedical diagnostics, by world regions and countries, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.12
    • 3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000- 2010), for nanotechnology in medical and biomedical diagnostics, by world regions and countries, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.13
    • 3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in medical and biomedical diagnostics, by world regions and countries, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.14
    • 3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in medical and biomedical diagnostics, all world regions and countries studied, source: Cientifica (all figures in percentage).
  • Exhibit 4.15
    • Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in medical and biomedical diagnostics, all world regions and countries studied, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.16
    • 3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in medical and biomedical diagnostics, European Union countries studied, source: Cientifica (all figures in percentage).
  • Exhibit 4.17
    • Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in medical and biomedical diagnostics, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.18
    • Line chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in medical and biomedical diagnostics, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.19
    • 3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000- 2010), for nanotechnology in medical and biomedical diagnostics, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.20
    • 3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in medical and biomedical diagnostics, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.21
    • 3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in medical and biomedical diagnostics, Asian countries studied, source: Cientifica (all figures in percentage).
  • Exhibit 4.22
    • Horizontal bar graph representing the Total Addressable Market, TAM In 2010, for nanotechnology in medical and biomedical diagnostics, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.23
    • Line chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in medical and biomedical diagnostics, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.24
    • 3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000- 2010), for nanotechnology in medical and biomedical diagnostics, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.25
    • 3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in medical and biomedical diagnostics, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.26
    • Table representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in medical and biomedical diagnostics, all most relevant key technologies, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.27
    • 3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in medical and biomedical diagnostics, all key technologies studied, source: Cientifica (all figures in percentage).
  • Exhibit 4.28
    • Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in medical and biomedical diagnostics, all key technologies studied, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.29
    • Line chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in medical and biomedical diagnostics, all key technologies studied, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.30
    • 3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000- 2010) , for nanotechnology in medical and biomedical diagnostics, all key technologies studied, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.31
    • 3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010) , for nanotechnology in medical and biomedical diagnostics, all key technologies studied, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.32
    • 3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in medical and biomedical diagnostics, technological approaches as a whole, source: Cientifica (all figures in percentage).
  • Exhibit 4.33
    • Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in medical and biomedical diagnostics, technological approaches as a whole, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.34
    • Line chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in medical and biomedical diagnostics, technological approaches as a whole, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.35
    • 3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000- 2010) , for nanotechnology in medical and biomedical diagnostics, technological approaches as a whole, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.36
    • 3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010) , for nanotechnology in medical and biomedical diagnostics, technological approaches as a whole, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.37
    • 3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in medical and biomedical diagnostics, technological applications as a whole, source: Cientifica (all figures in percentage).
  • Exhibit 4.38
    • Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in medical and biomedical diagnostics, technological applications as a whole, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.39
    • Line chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in medical and biomedical diagnostics, technological applications as a whole, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.40
    • 3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000- 2010) , for nanotechnology in medical and biomedical diagnostics, technological applications as a whole, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.41
    • 3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010) , for nanotechnology in medical and biomedical diagnostics, technological applications as a whole, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.42
    • 3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in medical and biomedical diagnostics, impact of early disease detection, source: Cientifica (all figures in percentage).
  • Exhibit 4.43
    • Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in medical and biomedical diagnostics, impact of early disease detection, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.44
    • Line chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in medical and biomedical diagnostics, impact of early disease detection, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.45
    • 3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000- 2010) , for nanotechnology in medical and biomedical diagnostics, impact of early disease detection, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.46
    • 3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010) , for nanotechnology in medical and biomedical diagnostics, impact of early disease detection, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.47
    • Table representing the Total Addressable Market, TAM forecast by 2021 (for the 2011- 2021 period), for nanotechnology in medical and biomedical diagnostics, by world regions / countries, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.48
    • 3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in medical and biomedical diagnostics, by world regions, source: Cientifica (all figures in percentage).
  • Exhibit 4.49
    • Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in medical and biomedical diagnostics, by world regions, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.50
    • Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, by world regions, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.51
    • 3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, by world regions, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.52
    • 3-D stacked area chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, by world regions, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.53
    • 3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in medical and biomedical diagnostics, by all world regions / countries studied, source: Cientifica (all figures in percentage).
  • Exhibit 4.54
    • Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in medical and biomedical diagnostics, by all world regions / countries studied, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.55
    • Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, by all world regions / countries studied, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.56
    • 3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, by all world regions / countries studied, source: Cientifica (all figures US$
  • Million Dollars).
  • Exhibit 4.57
    • 3-D stacked area chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, by all world regions / countries studied, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.58
    • 3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in medical and biomedical diagnostics, European Union countries studied, source: Cientifica (all figures in percentage).
  • Exhibit 4.59
    • Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in medical and biomedical diagnostics, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.60
    • Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.61
    • 3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.62
    • 3-D stacked area chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.63
    • 3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in medical and biomedical diagnostics, Asian countries studied, source: Cientifica (all figures in percentage).
  • Exhibit 4.64
    • Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in medical and biomedical diagnostics, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.65
    • Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diag ostics, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.66
    • 3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.67
    • 3-D stacked area chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and bio edical diagnostics, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.68
    • Table representing the Total Addressable Market, TAM forecast by 2021 (for the 2011- 2021 period), for nanotechnology in medical and biomedical diagnostcs, all most relevant key technologies, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.69
    • 3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in medical and biomedical diagnostics, all key technologies studied, source: Cientifica (all figures in percentage).
  • Exhibit 4.70
    • Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in medical and biomedical diagnostics, all key technologies studied, source: Cientifica (all figures in percentage).
  • Exhibit 4.71
    • Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, all key technologies studied, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.72
    • 3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, all key technologies studied, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.73
    • 3-D stacked area chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, all key technologies studied, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.74
    • 3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in medical and biomedical diagnostics, technological approaches as a whole, source: Cientifica (all figures in percentage).
  • Exhibit 4.75
    • Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in medical and biomedical diagnostics, technological approaches as a whole, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.76
    • Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, technological approaches as a whole, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.77
    • 3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, technological approaches as a whole, source: Cientifica (all figures US$ Million
  • Dollars).
  • Exhibit 4.78
    • 3-D stacked area chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, technological approaches as a whole, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.79
    • 3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in medical and biomedical diagnostics, technological applications as a whole, source: Cientifica (all figures in percentage).
  • Exhibit 4.80
    • Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in medical and biomedical diagnostics, technological applications as a whole, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.81
    • Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, technological applications as a whole, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.82
    • 3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, technological applications as a whole, source: Cientifica (all figures US$ Million
  • Dollars).
  • Exhibit 4.83
    • 3-D stacked area chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, technological applications as a whole, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.84
    • 3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in medical and biomedical diagnostics, impact of early disease detection, source: Cientifica (all figures in percentage).
  • Exhibit 4.85
    • Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in medical and biomedical diagnostics, impact of early disease detection, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.86
    • Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, impact of early disease detection, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.87
    • 3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, impact of early disease detection, source: Cientifica (all figures US$ Million
  • Dollars).
  • Exhibit 4.88
    • 3-D stacked area chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical and biomedical diagnostics, impact of early disease detection, source: Cientifica (all figures US$ Million Dollars).
  • Exhibit 4.89
    • SWOT analysis to evaluate the strengths, weaknesses, opportunities and threats involved in nanotechnology in medical and biomedical diagnostics, in the scope of the technology adoption roadmap (during the 2011-2021 period).

APPENDIX

  • Exhibit A.1
    • Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: North America; country: USA.
    • Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.
  • Exhibit A.2
    • Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: European Union; country: Germany.
    • Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.
  • Exhibit A.3
    • Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: European Union; country: France.
    • Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.
  • Exhibit A.4
    • Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: European Union; country: UK.
  • Exhibit A.5
    • Table of the organizations with publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. Country: Russian Federation.
    • Organizations are ordered alphabetically (increasing order).
  • Exhibit A.6
    • Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: India.
    • Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.
  • Exhibit A.7
    • Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: India.
    • Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.
  • Exhibit A.8
    • Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: Japan.
    • Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.
  • Exhibit A.9
    • Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: P R China.
    • Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.
  • Exhibit A.10
    • Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: South Korea (Republic of Korea).
    • Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.
  • Exhibit A.11
    • Table of the organizations with publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. Asia; country: Taiwan.
Show More
Pricing